Skip to Content

  • Search

View Additional Section Content

S1404-A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT02506153?term=s1404&rank=1

Clinical Trial Categories

  • Melanoma
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details